World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT01995123
Date of registration: 20/11/2013
Prospective Registration: Yes
Primary sponsor: VA Office of Research and Development
Public title: Behavioral Activation for Smoking Cessation in PTSD
Scientific title: Behavioral Activation for Smoking Cessation in Veterans With PTSD
Date of first enrolment: September 8, 2014
Target sample size: 124
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01995123
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Investigator, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
United States
Contacts
Name:     Jessica M Cook, PhD
Address: 
Telephone:
Email:
Affiliation:  William S. Middleton Memorial Veterans Hospital, Madison, WI
Key inclusion & exclusion criteria

Inclusion Criteria:

- Report smoking an average of 10 or more cigarettes daily for at least six months

- Report a desire to quit smoking

- Meet criteria for current PTSD

- Speak and read English

- Agree to participate in the study

- Be 18 years old

- Be a veteran

Exclusion Criteria:

- Meeting criteria for psychotic or bipolar disorder

- Psychoactive substance abuse or dependence (excluding nicotine dependence) within the
past 6 months

- Inability to give informed, voluntary, written consent to participate

- Current use of any pharmacotherapy for smoking cessation not provided by the
researchers during the quit attempt

- Use of non-cigarette tobacco products as a primary form of tobacco use

- Being currently suicidal or homicidal

- Being medically unable to use the nicotine patch or nicotine gum/lozenge

- Psychotropic medication changes within 3 months of study initiation and during active
treatment

- Current engagement in evidence-based therapies for PTSD or depression

- Pregnant or trying to become pregnant

- Incarceration



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Tobacco Dependence
PTSD
Intervention(s)
Behavioral: Health and Smoking Education
Behavioral: Behavioral Activation Therapy
Behavioral: Standard Smoking Cessation Therapy
Primary Outcome(s)
Percentage of Participants Who Abstained From Smoking [Time Frame: 26 weeks post target quit date]
Secondary Outcome(s)
Clinician Administered PTSD Scale Score [Time Frame: 4 weeks post target quit date (end of treatment)]
Time to Smoking Relapse [Time Frame: 26 weeks post target quit date]
Secondary ID(s)
MHBA-002-12F
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University of Wisconsin, Madison
Ethics review
Results
Results available: Yes
Date Posted: 15/04/2020
Date Completed:
URL: https://clinicaltrials.gov/ct2/show/results/NCT01995123
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history